Aurobindo Pharma sets eyes on CRAMS

Updated on 26 June 2012

"These are potentially attractive businesses with possible long-term relationships. With the technology platform and skilled professionals available both at R&D center and in production facilities, Aurobindo is able to offer products and services that the customers want," said Mr K Nityanand Reddy, managing director, Aurobindo Pharma.

Aurobindo has designed short and medium-term plans to increase the product volume and meet customer expectations. It is also looking forward to achieve higher market share and step up the volume of business in the US, Europe and Japan. Aurobindo aims to emerge as a more global enterprise and to penetrate in China, Brazil and other Latin American countries through joint ventures and subsidiaries.

Previous 1 2 Next

Leave a Reply

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X